Price Alert

Monte Rosa Therapeutics I... (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

4.56

-0.02 (-0.44%)

At close: Aug 18, 2025, 3:59 PM

4.47

-1.97%

After-hours: Aug 18, 2025, 04:59 PM EDT

-0.44% (1D)

Bid	4.4
Market Cap	281.62M
Revenue (ttm)	159.49M
Net Income (ttm)	6.15M
EPS (ttm)	0.39
PE Ratio (ttm)	11.69
Forward PE	-3.04
Analyst	Hold

Ask	5
Volume	306,953
Avg. Volume (20D)	452,561
Open	4.58
Previous Close	4.58
Day's Range	4.45 - 4.65
52-Week Range	3.50 - 12.40
Beta	1.42

About GLUE

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol GLUE

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for GLUE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Monte Rosa Therapeutics Inc. is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

9 months ago

+93.87%

Monte Rosa Therapeutics shares are trading higher ... Unlock content with Pro Subscription

News

1 week ago · zacks.com

Monte Rosa Therapeutics (GLUE) Reports Q2 Loss, Tops Revenue Estimates

Monte Rosa Therapeutics (GLUE) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.43 per share a year ago.

2 months ago · zacks.com

Wall Street Analysts Think Monte Rosa Therapeutics (GLUE) Could Surge 222.16%: Read This Before Placing a Bet

The mean of analysts' price targets for Monte Rosa Therapeutics (GLUE) points to a 222.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreeme...